JRI 

The Protective Effects of Melatonin on the Histological Changes of Testis in Busulfan-Treated Adult Mice

Vol. 11, Issue 2, / July-September 2010
(pages 67-76)

Fahimeh Mohammadghasemi Corresponding Author
- Histotechnical Laboratory, Histology Group, Department of Anatomical Sciences, Faculty of Medicine, Gilan University of Medical Sciences, Rasht, Iran
Masoumeh Faghani
- Histotechnical Laboratory, Histology Group, Department of Anatomical Sciences, Faculty of Medicine, Gilan University of Medical Sciences, Rasht, Iran
Sina Khajeh Jahromi
- Medical Students Research Center Committee, Gilan University of Medical Sciences, Rasht, Iran

Received: 6/27/2009 Accepted: 11/10/2009 - Publisher : Avicenna Research Institute

Related Articles
in Google Scholar
in PubMed

 

Other Format
pdfFull Text (En)
pdfFull Text (Fa)
pdfAbstract (En)
pdfAbstract (Fa)
pdfePUB (En)
pdfBibTeX
pdfRefMan
pdfEndNote
xmlPMC XML
online readerPMC Reader
online readerHBIs XML

 


Abstract

Introduction: Antineoplastic chemotherapy is usually accompanied by fertility impairment and the aim of this study was to investigate the possible protective effects of melatonin, a pineal gland hormone with potent antioxidant activity, on busulfan-treated adult male mice. Materials and Methods: This study was performed on 32, eight-week old adult male mice. The animals were divided into four groups consisting of a control and three experimental groups. The animals in the control group received dimethyl sulfoxide (DMSO), a solvent, the second group a single dose of intraperitoneal busulfan (20 mg/kg), the third group a single dose of intraperitoneal melatonin (10 mg/kg) for five days and the fourth group melatonin (10 mg/kg) for five days upon an initial dose of busulfan (20 mg/kg). Thirty-five days after the treatments, all the animals were sacrificed and dissected. Johnson's score were determined by examining the morphometric characteristics of seminiferous tubules and estimating Leydig cell volumes and germ cell counts. Results: Busulfan-treated mice showed reductions in Johnson's score and quality of spermatogenesis (p < 0.001) in comparison to the controls. The quantitative values of seminiferous tubules (p < 0.05) and the nuclear volume of Leydig cells (p < 0.05) were significantly lower in the busulfan-treated mice relative to the controls. In the fourth group, melatonin not only caused a remarkable normalization in seminiferous tubule indices (p < 0.05), but also increased the nuclear volume of Leydig cells (p < 0.001), the relevant Johnson's score (p < 0.001) and all germ cells in comparison to the second group (p < 0.05). Conclusion: Melatonin might have a possible protective effect against busulfan-induced testicular damage. Although the protective mechanism of melatonin has not been fully revealed, the protection seems to be through a decrease in oxidative stress.


Keywords: Antineoplastic chemotherapy, Busulfan, Leydig cell, Melatonin, Spermatogenesis, Testis, Male infertility


To cite this article:



Figures, Charts, Tables













References

  1. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12-7.   [PubMed]
  2. Schrader M, Müller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol. 2001;15(6):611-7.   [PubMed]
  3. Udagawa K, Ogawa T, Watanabe T, Tamura Y, Kita K, Mitsumasa T, Hosaka M. GnRH analog, leupro-relinacetate acetate, promotes regeneration of rat spermatogenesis after severe chemical damage. Int J Urol. 2001;8(11):615-22.   [PubMed]
  4. Brinster RL, Zimmermann JW. Spermatogenesis following male germ-cell transplantation. Proc Natl Acad Sci U S A. 1994;91(24):11298-302.   [PubMed]
  5. Nagano M, Avarbock MR, Brinster RL. Pattern and kinetics of mouse donor spermatogonial stem cell colonization in recipient testes. Biol Reprod. 1999; 60(6):1429-36.   [PubMed]
  6. Brinster CJ, Ryu BY, Avarbock MR, Karagenc L, Brinster RL, Orwig KE. Restoration of fertility by germ cell transplantation requires effective recipient preparation. Biol Reprod. 2003;69(2):412-20.   [PubMed]
  7. Brinster RL. Germline stem cell transplantation and transgenesis. Science. 2002;296(5576):2174-6.   [PubMed]
  8. Sanchez-Hidalgo M, de la Lastra CA, Carrascosa-Salmoral MP, Naranjo MC, Gomez-Corvera A, Caballero B, et al. Age-related changes in melatonin synthesis in rat extrapineal tissues. Exp Gerontol. 2009;44(5):328-34.   [PubMed]
  9. Hussein MR, Abu-Dief EE, Abou El-Ghait AT, Adly MA, Abdelraheem MH. Morphological evaluation of the radioprotective effects of melatonin against X-ray-induced early and acute testis damage in Albino rats: an animal model. Int J Exp Pathol. 2006;87(3):237-50.   [PubMed]
  10. Reiter RJ, Tan DX, Manchester LC, Qi W. Bio-chemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys. 2001;34:237-56.   [PubMed]
  11. Sönmez M, Yüce A, Türk G. The protective effects of melatonin and Vitamin E on antioxidant enzyme activities and epididymal sperm characteristics of homocysteine treated male rats. Reprod Toxicol. 2007;23(2):226-31.   [PubMed]
  12. Gavella M, Lipovac V. Antioxidative effect of melatonin on human spermatozoa. Arch Androl. 2000;44(1):23-7.   [PubMed]
  13. Gwayi N, Bernard RT. The effects of melatonin on sperm motility in vitro in Wistar rats. Andrologia. 2002;34(6):391-6.   [PubMed]
  14. Guneli E, Tugyan K, Ozturk H, Gumustekin M, Cilaker S, Uysal N. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats. Eur Surg Res. 2008;40(4):354-60.   [PubMed]
  15. Ateşşahin A, Sahna E, Türk G, Ceribaşi AO, Yilmaz S, Yüce A, et al. Chemoprotective effect of melatonin against cisplatin-induced testicular tox-icity in rats. J Pineal Res. 2006;41(1):21-7.   [PubMed]
  16. Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol. 2002;54(10):1299-321.   [PubMed]
  17. Lewis-Johnes DI, Kerrigan DD. A modified johnsen's count for evaluation of spermatogenesis in the rat. IRCS Med Sci. 1985;13:510-11.
  18. Redins CA, Redins GM, Novaes JC. The effects of treatment with melatonin on the ultrastructure of mouse Leydig cells: a quantitative study. Braz J Biol. 2002;62(3):517-23.   [PubMed]
  19. Bucci LR, Meistrich ML. Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations. Mutat Res. 1987;176(2):259-68.   [PubMed]
  20. Koruji M, Movahedin M, Mowla SJ, Gourabi H, Arfaee AJ. The morphological changes of adult mouse testes after 60Co gamma-Radiation. Iran Biomed J. 2008;12(1):35-42.   [PubMed]
  21. van Keulen CJ, de Rooij DG. Spermatogenetic clones developing from repopulating stem cells surviving a high dose of an alkylating agent. Cell Tissue Kinet. 1975;8(6):543-51.   [PubMed]
  22. Newton SC, Blaschuk OW, Millette CF. N-cadherin mediates Sertoli cell-spermatogenic cell adhesion. Dev Dyn. 1993;197(1):1-13.   [PubMed]
  23. Choi YJ, Ok DW, Kwon DN, Chung JI, Kim HC, Yeo SM, et al. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL–and p53-inde-pendent manner. FEBS Lett. 2004;575(1-3):41-51.   [PubMed]
  24. Mohammad Ghasemi F, Soleimanirad J, Ghanbari AA. [An ultrastructural study on the apoptotic features of spermatogenic cells following busulfan treatment in adult mice]. J Reprod Infertil. 2007;8 (4):319-29.Persian   [Abstract]
  25. Mohamad Ghasemi F. [Ultrastructural evaluation and study of incidence of apoptosis in adult mouse testis following treatment with busulfan and GnRH analog supportive therapy] [Dissertation]. [Tabriz]: Tabriz University Of Medical Sciences; 2006 Jully. Part 3, Results; p. 110-18. Persian.
  26. Howell SJ, Shalet SM. Testicular function following chemotherapy. Hum Reprod Update. 2001;7 (4):363-9.   [PubMed]
  27. Qin DN, Lung MA. Morphometric study on leydig cells in capsulotomized testis of rats. Asian J Androl. 2002;4(1):49-53.   [PubMed]
  28. Mendis-Handagama SM, Kerr JB, De Kretser DM. Experimental cryptorchidism in the adult mouse. III. Qualitative and quantitative electron micro-scopic morphology of Leydig cells. J Androl. 1991;12(5):335-43.   [PubMed]
  29. França LR, Godinho CL. Testis morphometry, seminiferous epithelium cycle length, and daily sperm production in domestic cats (Felis catus). Biol Reprod. 2003;68:1554-61.   [PubMed]
  30. Chatterjee R, Mills W, Katz M, McGarrigle HH, Goldstone AH. Germ cell failure and Leydig cell insufficiency in post-pubertal males after auto-logous bone marrow transplantation with BEAM for lymphoma. Bone Marrow Transplant. 1994;13 (5):519-22.   [PubMed]
  31. Moisan AE, Foster RA, Betteridge KJ, Hahnel AC. Dose-response of RAG2-/-/gammac-/- mice to busulfan in preparation for spermatogonial transplantation. Reproduction. 2003;126(2):205-16.   [PubMed]
  32. Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet. 1981;1(8230):1132-4.   [PubMed]
  33. Mohamad Ghasemi F, Bahadori MH, Faghani M, Nasiri E, Soleimani Rad J. [Buserelin inhibits apoptosis in male germ cells induced by busulfan in mouse testis]. J Iran Anat Sci. 2009(7):45-54. Persian.
  34. Udagawa K, Ogawa T, Watanabe T, Tamura Y, Kita K, Kubota Y. Testosterone administration promotes regeneration of chemically impaired spermatogenesis in rats. Int J Urol. 2006;13(8): 1103-8.   [PubMed]
  35. Jafarian A, Akhondi MM, Pezhhan N, Sadeghi MR, Zarnani AH, Salehkhou S. [Stimulatory effects of Estradiol and FSH on the restoration of spermatogenesis in azoospermic mice]. J Reprod Infertil. 2008;9(4):317-24. Persian.   [Abstract]
  36. Johnston JD, Messager S, Ebling FJ, Williams LM, Barrett P, Hazlerigg DG. Gonadotrophin-releasing hormone drives melatonin receptor down-regulation in the developing pituitary gland. Proc Natl Acad Sci U S A. 2003;100(5):2831-5.   [PubMed]
  37. d'Istria M, Serino I, Izzo G, Ferrara D, De Rienzo G, Minucci S. Effects of melatonin treatment on Leydig cell activity in the testis of the frog Rana esculenta. Zygote. 2004;12(4):293-9.   [PubMed]
  38. Tam CW, Chan KW, Liu VW, Pang B, Yao KM, Shiu SY. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance. J Pineal Res. 2008;45(4):403-12.   [PubMed]
  39. Pizarro JG, Yeste-Velasco M, Esparza JL, Verdaguer E, Pallàs M, Camins A, et al. The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J Pineal Res. 2008; 45(1):8-16.   [PubMed]

COPE
SID
NLM
AJMB
IJBMLE
IJBMLE

Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.